Official Title
Prospective Parallel-Group Study of the Relationship Between Kidney Injury Severity and Severity of COVID-19
Brief Summary

The authors hypothesize that the SARS-CoV-2 virus can affect the kidneys, causing them to be damaged. The present study aims to explain the mechanisms of kidney injury in patients diagnosed with COVID-19.

Detailed Description

In December 2019, an outbreak of the 2019 novel coronavirus disease (COVID-19) caused by the
SARS coronavirus 2 (SARS-CoV-2) occurred in Wuhan, China. It has spread rapidly to other
areas in China and worldwide. The most common manifestations of COVID-19 included fever, dry
cough, dyspnea, myalgia, fatigue and radiographic evidence of pneumonia. Complications (acute
respiratory distress syndrome, shock, acute cardiac injury, secondary infection, and acute
kidney injury) and death may occur in severe cases. Recent reports showed that extrapulmonary
symptoms (intestinal symptoms in 10-20% of patients) and renal failure in some patients may
be associated with the interaction of the virus with angiotensin-converting enzyme 2 (ACE-2)
receptors in other organs. It was suggested that ACE-2 expression in the kidneys can be the
cause of kidney injury occurring in a number of patients with SARS-CoV-2.However, ACE-2 is
not the only possible cause of kidney injury - sepsis-related cytokine storm can also lead to
damage of kidney parenchyma.

The present study aims to explain the mechanisms of kidney injury in patients diagnosed with
COVID-19.

Completed
COVID-19
Kidney Injury

Diagnostic Test: mRNA in urine test

Assessment of renal function, expression of viral RNA in urine and assessment of radiological changes will be performed
Other Name: Array

Eligibility Criteria

Inclusion Criteria:

- Pneumonia confirmed by CT scans

Exclusion Criteria:

- a history of chronic renal failure;

- a history of kidney transplantation;

- intake of substances with a history of renal toxicity (no later than a month before
inclusion);

- patients with a single kidney;

- refusal of the patient to participate in the study;

- absence of SARS-CoV-2 virus smear from the nasopharynx in PCR.

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
Russian Federation
Locations

Sechenov University.
Moscow, Russian Federation

Dmitry Enikeev, M.D., Ph.D., Principal Investigator
Sechenov University

I.M. Sechenov First Moscow State Medical University
NCT Number
Keywords
Coronavirus infection
Kidney Function
MeSH Terms
COVID-19
Wounds and Injuries